Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
PPH
VanEck Pharmaceutical ETF
115.5
8
USD
-0.01%
Market Price
Sector:
Financial
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
-0.65%
Monthly Change
+3.46%
6 month change
+14.00%
Year Change
+25.74%
Previous Close
116.3
4
Open
115.5
7
Low
115.0
8
High
116.0
4
Markets
US ETFs
PPH
1D
1W
1M
3M
6M
YTD
1Y
5Y
Open full chart
Overview
All holdings
Heatmap
Top holdings
Market Value
Shares
Weight %
LLY
Eli Lilly & Co
177.92 M
148.34 K
20.23%
NVS
Novartis AG
93.44 M
596.25 K
10.63%
MRK
Merck & Co Inc
86.58 M
673.80 K
9.85%
NVO
Novo Nordisk A/S
47.19 M
984.36 K
5.37%
ABBV
AbbVie Inc
40.23 M
159.88 K
4.57%
PFE
Pfizer Inc
39.64 M
1.65 M
4.51%
BMY
Bristol-Myers Squibb Co
39.30 M
682.12 K
4.47%
GSK
GSK PLC
38.85 M
741.18 K
4.42%
JNJ
Johnson & Johnson
38.30 M
150.79 K
4.35%
A
AZN
AstraZeneca PLC
38.11 M
200.97 K
4.33%
MCK
McKesson Corp
36.25 M
47.98 K
4.12%
SNY
Sanofi SA
35.21 M
825.43 K
4.00%
COR
Cencora Inc
29.51 M
104.30 K
3.36%
HLN
Haleon PLC
27.18 M
2.91 M
3.09%
TEVA
Teva Pharmaceutical Industries Ltd
26.89 M
793.77 K
3.06%
TAK
Takeda Pharmaceutical Co Ltd
25.26 M
1.58 M
2.87%
ZTS
Zoetis Inc
18.46 M
256.85 K
2.10%
VTRS
Viatris Inc
9.63 M
606.44 K
1.10%
JAZZ
Jazz Pharmaceuticals PLC
9.50 M
39.44 K
1.08%
AXSM
Axsome Therapeutics Inc
6.75 M
27.59 K
0.77%
1
2
News
Market Concentration: Building For More Than One Outcome
Execution of Pharma Tariffs Brings These ETFs Into Focus
Should You Invest in the VanEck Pharmaceutical ETF (PPH)?
Equity Outlook: AI, Higher Rates Raise The Bar For Diversification
Where Healthcare Innovation Meets Investment Opportunity
David Rubenstein Of The Carlyle Group On The Business Of Sports, Investing And Leadership
'Anthropic quietly sets up biology lab as it ramps AI drug program' - Reuters Exclusive
Here's How Trump's Drug Deals Are Likely to Impact Healthcare ETFs
The Market May Be Telling Us We're Entering A Capital Formation Cycle
Trump’s MFN Policy Is Reshaping Global Pharma, Not Prices
Healthcare ETFs to Watch Post Merck-Moderna Cancer Vaccine Breakthrough
FDA Nods Lilly-Roche's Alzheimer's Blood Test: Healthcare ETFs to Track Now